Antipsychotic interventions in prodromal psychosis: safety issues.
about
Chlorpromazine-Induced Hyperprolactinemia on Rat's UterusMaternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates.Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group.The Clinic for Assessment of Youth at Risk (CAYR): 10 years of service delivery and research targeting the prevention of psychosis in Montreal, Canada.Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders.Reply
P2860
Q28607320-787FF423-84AE-40CD-90DB-17C2AAE763E4Q30238718-E4D68C3A-B4E3-4547-8C53-68332D3A48F7Q38929213-A96EC0EF-625B-43B1-8046-495951AE9437Q47585327-FC5EEF67-7EFD-4F56-900E-EFF5CB2071F3Q50277555-3753DF8B-112B-4E17-8B6F-F7F847FCF163Q51094803-9648F1E2-06D2-4A16-9E86-9E578BA71FB9Q58809454-EA393E6F-15B9-4D2E-AEA0-9D39E1027BFC
P2860
Antipsychotic interventions in prodromal psychosis: safety issues.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antipsychotic interventions in prodromal psychosis: safety issues.
@en
type
label
Antipsychotic interventions in prodromal psychosis: safety issues.
@en
prefLabel
Antipsychotic interventions in prodromal psychosis: safety issues.
@en
P2860
P1433
P1476
Antipsychotic interventions in prodromal psychosis: safety issues.
@en
P2860
P2888
P304
P356
10.1007/S40263-013-0046-1
P577
2013-03-01T00:00:00Z